Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.

[1]  Y. Taniyama,et al.  Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.

[2]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[3]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[4]  M. Hori,et al.  Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. , 1995, Circulation.

[5]  D. Baim,et al.  Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.

[6]  S. Kaul,et al.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.

[7]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[8]  J. Shani,et al.  Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. , 1992, American heart journal.

[9]  D. Baim,et al.  Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. , 1991, Catheterization and cardiovascular diagnosis.

[10]  R. Kloner,et al.  Experimental infarct size reduction with calcium channel blockers. , 1991, Journal of the American College of Cardiology.

[11]  J. Calvin,et al.  Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. , 1991, Journal of the American College of Cardiology.

[12]  L. Becker,et al.  Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[13]  R. Virmani,et al.  Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. , 1989, Circulation.

[14]  C. White,et al.  INTENSE MICROVASCULAR CONSTRICTION AFTER ANGIOPLASTY OF ACUTE THROMBOTIC CORONARY ARTERIAL LESIONS , 1989, The Lancet.

[15]  J. Bristow,et al.  No reflow and extent of infarction during maximal vasodilation in the porcine heart. , 1988, Circulation.

[16]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[17]  A. Jaffe,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. , 1988, Journal of the American College of Cardiology.

[18]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[19]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .

[20]  E. Braunwald,et al.  Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. , 1986, Journal of the American College of Cardiology.

[21]  L. Becker,et al.  Selective enhancement of function of stunned myocardium by increased flow. , 1986, Circulation.

[22]  M. Cohen,et al.  Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. , 1986, Circulation.

[23]  W. O’Neill,et al.  Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. , 1986, The American journal of cardiology.

[24]  E. Braunwald,et al.  Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. , 1983, Circulation.

[25]  Y. Ikeda,et al.  Inhibition of Human Platelet Functions by Verapamil , 1981, Thrombosis and Haemostasis.

[26]  E. Antman,et al.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. , 1980, Annals of internal medicine.

[27]  E. Antman,et al.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.

[28]  E. Braunwald,et al.  Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.

[29]  E. Braunwald,et al.  Review: Observations on experimental myocardial ischaemia , 1980 .

[30]  E. Braunwald,et al.  Observations on experimental myocardial ischaemia. , 1980, Cardiovascular Research.

[31]  N. Maclean,et al.  S.L.E. AND KLINEFELTER'S SYNDROME , 1976, The Lancet.

[32]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.